The tip of a 6 x 4mm precise pro rx carotid stent delivery system (sds) was noted to be cracked and the stent was slightly deployed prior to use on a patient.They also reported that the stent became further deployed as they were passing the sds over the guidewire.The device was exchanged and the procedure successfully completed with no reported patient injury.The event involved an (b)(6) year old patient undergoing endovascular treatment of a highly stenosed lesion in his/her ¿left clavicle¿.The site reported that the sds had been stored and handled according to the instructions for use (ifu) and that no anomalies were noted to the device packaging.Prior to use on the patient, the site noted that the tip of the sds was cracked and the stent was slightly deployed.They also reported that the stent was being deployed inadvertently while they passing the sds over the guidewire.The sds was exchanged for another sds and the procedure successfully completed with no reported patient injury.One non-sterile precise pro rx ous carotid system, 5f, 6mm x 40mm, 135 cm was received coiled inside in plastic bag.The stent was received partially deployed (1cm) and the brite tip was received damaged.No other damages could be observed.Functional testing of the deployment process was successful.Sem of the frayed distal tip revealed evidence of elongation at the areas surrounding the fray.Elongation is a common characteristic of pieces which were stretched/ pulled.Stretching/ pulling could have been related to these characteristic.A review of the manufacturing records for this lot of products revealed that it met specification prior to release.The reported ¿catheter tip - frayed/split/torn¿ and ¿sds -deployment difficulty-premature deployment¿ events were confirmed based on the visual analysis.The cause of these events could not be conclusively determined.However, analysis of the product revealed evidence suggestive of pulling and/or stretching.According to the ifu, this device is indicated for use in patients with stenotic lesions of the carotid artery(ies).Users are cautioned that the device is shipped with the hemovalve in the open position.They are further instructed to be careful not to prematurely deploy the stent during preparation.The preparation of the device should be done in the tray with closure of the hemovalve prior to the device¿s removal from the tray.After removing the device from the tray, users are instructed to examine the device for any damage.They are to evaluate the distal end of the catheter to ensure that the stent is contained within the other sheath.They are instructed not to use the device if the stent is partially deployed.If the user suspects that the sterility or performance of the device has been compromised, they are instructed to not use the device.Based on the information available for review, there are procedural factors (evidence of stretching and continued use of the device after damage was noted) that may have contributed to the reported events.Neither the device history record review nor the product analysis suggests that the reported events could be related to the manufacturing process.Therefore, no corrective actions will be taken.
|